ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for tough pancreatic cancer
Disease control Recruiting nowThis study is testing a new drug called LM-108, given alongside an immunotherapy drug and two standard chemotherapy drugs, for people with advanced pancreatic cancer that cannot be removed by surgery. The main goals are to see if this combination is safe and if it can help contro…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 08:56 UTC
-
Scientists test Double-Punch cell therapy for tough pancreatic cancer
Disease control Recruiting nowThis early-phase study is testing a new two-part cell therapy for people with advanced pancreatic cancer that has stopped responding to standard treatments. It combines two types of specially prepared immune cells: one to help break down the tumor's defenses and another to seek o…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Engineered virus targets tough pancreatic tumors in new trial
Disease control Recruiting nowThis trial is testing a new treatment called hV01, which is a specially modified virus designed to infect and kill pancreatic cancer cells. It is for adults with advanced pancreatic cancer that has not responded to standard therapies. The virus is injected directly into the tumor…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC